Literature DB >> 22483667

The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.

Alan Ebringer1, Taha Rashid, Clyde Wilson.   

Abstract

Multiple sclerosis (MS) is an autoimmune neurological disorder. The role of 'Acinetobacter' has been examined using the method of Karl Popper and involves nine "Popper sequences". (1) The frequency of MS increases with latitudes in the Northern Hemisphere, and the reverse is found in the Southern Hemisphere. (2) Sinusitis is found frequently at colder latitudes. (3) Sinusitis occurs frequently in patients with MS. (4) Specific sequences of bovine myelin when injected into experimental animals will produce a neurological disorder resembling MS which is called "experimental allergic encephalomyelitis". (5) Computer analysis of myelin shows molecular mimicry with sequences found in Acinetobacter. (6) Antibodies to Acinetobacter bacteria are found in MS patients. (7) Acinetobacter bacteria are located on human skin and in the nasal sinuses. (8) IgA antibodies are preferentially elevated in the sera of MS patients, thereby suggesting the trigger microbe is acting across a mucosal surface probably located in the nasal sinuses. (9) Only Acinetobacter bacteria and no other microbes evoke statistically significant titres of antibodies in MS patients. These nine Popper sequences suggest that MS is most probably caused by infections with Acinetobacter bacteria in the nasal sinuses, and this could have therapeutic implications.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483667     DOI: 10.1016/j.mehy.2012.02.026

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.

Authors:  Patrick S C Leung; Jinjun Wang; Phornnop Naiyanetr; Thomas P Kenny; Kit S Lam; Mark J Kurth; M Eric Gershwin
Journal:  J Autoimmun       Date:  2013-01-24       Impact factor: 7.094

2.  Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.

Authors:  Vania Patrone; Edoardo Puglisi; Marco Cardinali; Tobias S Schnitzler; Silvia Svegliati; Antonella Festa; Armando Gabrielli; Lorenzo Morelli
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

Review 3.  The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle.

Authors:  Noha S Elsayed; Paula Aston; Vishnu R Bayanagari; Sanjay K Shukla
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

Review 4.  A review of serological tests to assist diagnosis of reactive arthritis: critical appraisal on methodologies.

Authors:  Tamara Tuuminen; Kari Lounamo; Marjatta Leirisalo-Repo
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.